MedPath

Improvement of Care of Patients Undergoing Pancreaticoduodenectomy

Not Applicable
Completed
Conditions
Pancreas Cancer
Pancreatic Diseases
Interventions
Procedure: Analgesia via epidural catheter
Procedure: Analgesia via wound catheter
Registration Number
NCT04668781
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The study is a randomised controlled trial comparing the effectivity and impact of epidural analgesia and wound catheter analgesia in patients undergoing pancreaticoduodenectomy. The aim of the study is to examine whether there are a difference in perioperative fluid therapy and complication rates between the patients in epidural and wound catheter groups.

Detailed Description

All patients undergoing pancreaticoduodenectomy in Helsinki University Hospital are recruited in the study. Patients meeting the inclusion criteria and giving consent to participate the study will be randomised to whether epidural analgesia group or wound catheter analgesia group. Both groups receive additional analgesia with intravenous PCA-oxycodone (patient controlled analgesia).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • age 18 years or over
  • patients who undergo pancreaticoduodenectomy
Exclusion Criteria
  • patients to whom are made a major vascular reconstruction
  • patients with significant comorbidities and inability to use PCA
  • regural use of strong opioids or drugs preoperatively
  • patients with severe chronic pain issues
  • chronic atrial fibrillation
  • patients who refuse to take part to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Epidural analgesiaAnalgesia via epidural catheter-
Wound catheter analgesiaAnalgesia via wound catheter-
Primary Outcome Measures
NameTimeMethod
The norepinephrine consumptionPostoperative day 0

Norepinephrine consumption on POD 0

Secondary Outcome Measures
NameTimeMethod
Fluid volumes on PODs 0-4Postoperative days 0-4

Intraoperative and postoperative fluid volumes

Oxycodone consumptionPostoperative days 1-4

Intravenous PCA opioid consumption.

Hospital length of stayPostoperative days 0-60
Postoperative complicationsPostoperative days 0-90

Clavien-Dindo complications (scale 0-5), pancreatic fistulas (ISGPF definition, grade A-C), postpancreatectomy hemorrage (IPGPS definition, grade A-C), delayed gastric emptying (ISGPS definition, grade A-C).

Reoperation ratesPostoperative days 0-90
Readmission ratesPostoperative days 0-90
Mortalitypostoperative day 0-90

Trial Locations

Locations (1)

Helsinki University Hospital

🇫🇮

Helsinki, HUS, Finland

© Copyright 2025. All Rights Reserved by MedPath